PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market
Rhea-AI Summary
PainReform (Nasdaq: PRFX) announced on January 5, 2026 that its DeepSolar unit launched Smart TDD, a lifecycle-wide solar Technical Due Diligence service targeting the global solar asset M&A market. Smart TDD combines 100% component and operational-history coverage, AI-driven analytics with physics-based modeling, expert engineering review, prioritized findings by financial impact, and preliminary results delivered within days. The release cites a large addressable market—$500 billion invested in 2024 and more than $60 billion of solar assets traded annually—and positions Smart TDD for use at commissioning, warranty expiry, underperformance remediation, and asset acquisitions.
Positive
- $60B in solar assets change hands annually (market context)
- $500B invested in solar in 2024 (market scale)
- Audits 100% of components and operational history
- Preliminary results delivered within days
- Combines AI analytics with physics-based modeling and engineering review
Negative
- None.
News Market Reaction – PRFX
On the day this news was published, PRFX declined 3.06%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Sector peers show mixed moves: AKAN up 9.25%, UPC up 7.49%, INM up 5.66%, while SHPH and RDHL are modestly down. With healthcare/drug peers not uniformly higher and this news focused on DeepSolar’s solar TDD platform, the stock’s move appears company‑specific rather than sector‑driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 30 | Partnership showcase | Positive | -7.0% | BladeRanger to showcase Solar Drone and DeepSolar cooperation at ADSW. |
| Dec 10 | Platform R&D update | Positive | +3.5% | LayerBio ocular platform confirmed to accommodate multiple drug entities. |
| Dec 02 | Clinical development | Positive | +2.4% | Commenced development toward Phase II trial for OcuRing‑K ocular therapy. |
| Nov 12 | AI engine progress | Positive | +9.3% | DeepSolar advanced AI‑driven automated reporting engine for solar assets. |
| Nov 05 | AI forecasting update | Positive | +6.7% | DeepSolar Predict progress and NVIDIA Connect coverage for PV forecasting. |
Recent DeepSolar and LayerBio announcements were generally followed by positive 24h price reactions, with only one notable divergence.
Over the last few months, PainReform combined its core healthcare activities with DeepSolar’s energy‑analytics initiatives. DeepSolar updates on AI‑driven reporting and NVIDIA Connect program participation in November 2025 coincided with positive moves of 9.26% and 6.67%. LayerBio’s ocular platform progress and OcuRing‑K Phase II planning in December 2025 also saw modest gains. A BladeRanger collaboration headline on Dec. 30, 2025 drew a -6.98% reaction, showing not all solar‑related exposure was rewarded. Today’s Smart TDD launch extends the DeepSolar commercialization narrative.
Market Pulse Summary
This announcement highlights the launch of Smart TDD, a lifecycle-wide solar Technical Due Diligence platform that audits 100% of components and targets a $60B+ global solar asset M&A market. It builds on earlier DeepSolar AI and reporting initiatives while PainReform also advances its LayerBio ocular programs. Investors may watch for evidence of commercial uptake, such as new mandates from independent power producers, infrastructure funds, or insurers, and how this non-core solar activity coexists with the company’s healthcare pipeline.
Key Terms
technical due diligence financial
independent power producers financial
m&a financial
physics-based modeling technical
AI-generated analysis. Not financial advice.
New lifecycle-wide audit platform provides complete data coverage, advanced diagnostics, and rapid turnaround, supporting investors, operators, insurers and lenders across commissioning, underperformance, warranty expiry, and asset transactions
TEL AVIV, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) today announced that its DeepSolar business unit has launched Smart TDD, an advanced solar Technical Due Diligence (“TDD”) service designed to provide faster, more accurate, and more comprehensive assessments of solar asset performance and risk. The newly enhanced service expands DeepSolar’s audit capabilities to support independent power producers (IPPs), infrastructure funds, operators, lenders, and insurers at every major lifecycle milestone of a solar asset.
Solar continues to experience historic global growth, with more than
“Solar energy production technical due diligence today is often superficial, incomplete, and slow,” said Ehud Geller, Chairman of PainReform. “With Smart TDD, we believe that DeepSolar is offering the market something fundamentally different: a fast, independent, full-picture audit so investors and owners can truly understand what they are acquiring, operating, or insuring—and unlock more value.”
Smart TDD is engineered to address the longstanding shortcomings of conventional TDD by combining four key elements:
- Complete data coverage: auditing
100% of components and operational history, not just sampling at one time point - Advanced diagnostics: fusing AI-driven analytics with physics-based modeling and expert engineering review
- Actionable output: clearly prioritized findings organized by financial impact and severity
- Fast turnaround: preliminary results delivered within days of data upload, reducing deal friction
With these capabilities, Smart TDD supports all major checkpoints in a solar plant’s life:
- Commissioning: verify build quality and confirm compliance with acceptance criteria
- Warranty expiry: identify hidden defects and potential claims before constructor coverage ends
- Underperformance: diagnose and address the sources of revenue loss
- Asset acquisition: provide buyers and financiers with a clear, detailed, fast, and independent picture of asset condition
“The growth of solar as the world’s leading source of new energy capacity has created a massive secondary market and lifecycle maintenance challenge,” Geller added. “DeepSolar’s Smart TDD is built with the goal of meeting that need with a level of completeness, accuracy, and speed that the market has not seen before.”
The launch of Smart TDD reinforces DeepSolar’s role as a trusted analytics partner for the global solar sector. As aging assets face increasing performance issues and M&A activity continues to accelerate, the demand for high-quality technical due diligence services is expected to rise sharply, and DeepSolar’s enhanced platform is designed to deliver at scale.
For more information, please visit: https://tdd.deepsolar.ai/
AboutDeep Solar
DeepSolar develops advanced digital-asset-management technologies for utility-scale solar plants. Its AI-driven algorithms transform complex operational data into actionable insights detecting issues, forecasting production, and improving decision-making to maximize asset performance and profitability. DeepSolar is an active participant in the NVIDIA Connect program (#NVIDIAConnect), supporting continued innovation in AI-powered renewable-energy solutions.
About PainReform
PainReform Ltd. (Nasdaq: PRFX) is a company focused on the reformulation of established therapeutics, and a developer of AI-driven energy optimization technologies through its DeepSolar platform. The Company’s pharmaceutical programs leverage a proprietary extended-release drug-delivery system intended to provide prolonged post-surgical pain relief while minimizing the need for repeated dosing and reducing reliance on opioids. Through DeepSolar, PainReform also delivers advanced software solutions that enable both consumers and enterprises to monitor, forecast, and optimize energy consumption—particularly in solar-integrated environments. This dual business model reflects PainReform’s strategic commitment to applying precision technology across high-impact sectors including healthcare and sustainable energy. For more information, please visit www.painreform.com.
Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements about PainReform’s expectations, beliefs and intentions including with respect to the ability of Smart TDD to support all major checkpoints in a solar plant’s life. Forward-looking statements can be identified by the use of forward-looking words such as “believe”, “expect”, “intend”, “plan”, “may”, “should”, “could”, “might”, “seek”, “target”, “will”, “project”, “forecast”, “continue” or “anticipate” or their negatives or variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical matters. These forward-looking statements are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and we undertake no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of our control. Many factors could cause our actual activities or results to differ materially from the activities and results anticipated in forward- looking statements, including, but not limited to, the following: our ability to continue as a going concern, our history of significant losses, our need to raise additional capital and our ability to obtain additional capital on acceptable terms, or at all; our dependence on the success of our initial product candidate, PRF-110 OcuRing™-K, LayerBio Inc.’s lead product candidate, and the commercialization of the DeepSolar solution; the outcomes of preclinical studies, clinical trials and other research regarding PRF-110, OcuRing™-K and future product candidates; our limited experience managing clinical trials; our ability to retain key personnel and recruit additional employees; our reliance on third parties for the conduct of clinical trials, product manufacturing and development; the impact of competition and new technologies; our ability to comply with regulatory requirements relating to the development and marketing of our product candidates; our ability to establish and maintain strategic partnerships and other corporate collaborations; the implementation of our business model and strategic plans for our business and product candidates; the scope of protection we are able to establish and maintain for intellectual property rights and our ability to operate our business without infringing the intellectual property rights of others; the overall global economic environment; our ability to develop an active trading market for our ordinary shares and whether the market price of our ordinary shares is volatile; our ability to maintain our listing on the Nasdaq Capital Market; and statements as to the impact of the political and security situation in Israel on our business. More detailed information about the risks and uncertainties affecting us is contained under the heading “Risk Factors” included in the Company’s most recent Annual Report on Form 20-F and in other filings that we have made and may make with the Securities and Exchange Commission in the future.
Contact:
Crescendo Communications, LLC
Tel: 212-671-1021
Email: prfx@crescendo-ir.com
Dr. Ehud Geller
Chairman and interim Chief Executive Officer
PainReform Ltd.
Tel: +972-54-4236711
Email: egeller@medicavp.com